Mike Fitzpatrick

Mike is Managing Principal of NINE75, a healthcare business, and operations strategy company, and is an accomplished leader with over 20 years of broad experience in biopharma drug, medical device and healthcare development and corporate management. He has extensive strategic, financial, and operational expertise, with experience in business financial operations, investor and media relations, portfolio planning, project and alliance management, protein biochemistry, and process development. Most recently, Mike was CEO and President of NanoScopia, Inc., a medical device research and development company. Mike worked for nearly 20 years at ZymoGenetics, a Seattle-based biotech company, and subsidiary of Bristol Myers-Squibb. Mike held positions of increasing responsibility in several departments during his tenure at ZymoGenetics, culminating in his role as Site Lead & Director of Operations. Mike holds a BBA in finance from the University of Notre Dame and a BS in genetics and cell biology from the University of Minnesota.